APA (7th ed.) Citation

Flörkemeier, I., Hotze, H. L., Heyne, A. L., Hildebrandt, J., Weimer, J. P., Hedemann, N., . . . Bauerschlag, D. O. (2025). Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma †. International Journal of Molecular Sciences, 26(7), 2829. https://doi.org/10.3390/ijms26072829

Chicago Style (17th ed.) Citation

Flörkemeier, Inken, et al. "Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma †." International Journal of Molecular Sciences 26, no. 7 (2025): 2829. https://doi.org/10.3390/ijms26072829.

MLA (9th ed.) Citation

Flörkemeier, Inken, et al. "Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma †." International Journal of Molecular Sciences, vol. 26, no. 7, 2025, p. 2829, https://doi.org/10.3390/ijms26072829.